AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Company Description
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.
The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide.
It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics.
The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services.
The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce.
Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
Country | United States |
IPO Date | Nov 18, 1999 |
Industry | Medical - Diagnostics & Research |
Sector | Healthcare |
Employees | 17,400 |
CEO | Rodney Gonsalves |
Contact Details
Address: 5301 Stevens Creek Boulevard Santa Clara, California United States | |
Website | https://www.agilent.com |
Stock Details
Ticker Symbol | A |
Exchange | NYSE |
Fiscal Year | November - October |
Reporting Currency | USD |
CIK Code | 0001090872 |
CUSIP Number | 00846U101 |
ISIN Number | US00846U1016 |
Employer ID | 77-0518772 |
SIC Code | 3826 |
Key Executives
Name | Position |
---|---|
Bret M. DiMarco | Senior Vice President, Chief Legal Officer, & Secretary |
John Kohl | Senior Vice President & Chief Information Officer |
Angelica Riemann III | Senior Vice President |
Dominique P. Grau | Senior Vice President of Human Resources & Global Communications |
Dr. Simon May | SVice President of Agilent & President of Diagnostics & Genomics Group |
Jenipher E. Dalton | Senior Vice President, Chief Quality & Regulatory Officer |
Jonah Kirkwood | Senior Vice President |
Philip Binns | Senior Vice President of Agilent and President of Life Sciences & Applied Markets Group |
Rodney Gonsalves | Principal Accounting Officer, Vice President & Corporate Controller |
Yvonne Mackie | MD of UK & Ireland Operations and Vice President of Human Resources - Europe |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Dec 20, 2024 | 10-K | Annual Report |
Dec 13, 2024 | 8-K | Current Report |
Dec 03, 2024 | 4 | Filing |
Dec 02, 2024 | 4 | Filing |
Dec 02, 2024 | 4 | Filing |
Dec 02, 2024 | 4 | Filing |
Dec 02, 2024 | 4 | Filing |
Dec 02, 2024 | 4 | Filing |
Dec 02, 2024 | 4 | Filing |
Dec 02, 2024 | 4 | Filing |